Lassa Fever and Septic Fever: Clinical Profiles, Risk Factors, and Predictors of Mortality, Analysis of Early Clinical Predictors and Biomarkers, Global & India Mapping the Co-Prevalence, AI and 3D Identification

Keywords

Abstract

References

1. [1]1. Alexandrov, I. A., Kuklin, V. Z., Muranov, A. N., & Polezhaev, D. V. (2024). Developing an algorithm for Real-Time 3D identification of images. Engineering Journal, 28(5), 83-94.
2. [2]2. Aronson, J. K., & Ferner, R. E. (2017). Biomarkers—a general review. Current protocols in pharmacology, 76(1), 9-23.
3. [3]3. Asogun, D. A., Günther, S., Akpede, G. O., Ihekweazu, C., & Zumla, A. (2019). Lassa fever: epidemiology, clinical features, diagnosis, management and prevention. Infectious Disease Clinics, 33(4), 933-951.
4. [4]4. Balcan, B., Olgun, Ş., Torlak, F., Sağmen, S. B., Eryüksel, E., & Karakurt, S. (2015). Determination of factors affecting mortality of patients with sepsis in a tertiary intensive care unit. Turkish Thoracic Journal, 16(3), 128.
5. [5]5. Bhattacharya, P. K., Murti, V. S., Jamil, M., & Barman, B. (2020). Clinical profile and determinants of scrub typhus presenting with sepsis based on Sepsis-3 criteria. Journal of Vector Borne Diseases, 57(4), 307-313.
6. [6]6. Chowdhury, M. Z. I., & Turin, T. C. (2020). Variable selection strategies and its importance in clinical prediction modelling. Family medicine and community health, 8(1), e000262.
7. [7]7. Collins, G. S., Moons, K. G., Dhiman, P., Riley, R. D., Beam, A. L., Van Calster, B., ... & Logullo, P. (2024). TRIPOD+ AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. bmj, 385.
8. [8]8. Dolin, H. H., Papadimos, T. J., Chen, X., & Pan, Z. K. (2019). Characterization of pathogenic sepsis etiologies and patient profiles: a novel approach to triage and treatment. Microbiology insights, 12, 1178636118825081.
9. [9]9. Fathi, M., Markazi-Moghaddam, N., & Ramezankhani, A. (2019). A systematic review on risk factors associated with sepsis in patients admitted to intensive care units. Australian Critical Care, 32(2), 155-164.
10. [10]10. Ghaffar Nia, N., Kaplanoglu, E., & Nasab, A. (2023). Evaluation of artificial intelligence techniques in disease diagnosis and prediction. Discover Artificial Intelligence, 3(1), 5.
11. [11]11. Hashmat, N., Shabbir, I., Rahat, T., Ijaz, F., & Majeed, S. (2015). Clinical Profile and Disease Outcome of Septic Patients at Public Sector Hospital. Pakistan Journal of Medical Research, 54(2).
12. [12]12. Izah, S. C., Ovuru, K. F., & Ogwu, M. C. (2022). Lassa fever in Nigeria: social and ecological risk factors exacerbating transmission and sustainable management strategies. Int J Trop Dis, 5(2), 065.
13. [13]13. Joseph, A., Robinson, O., Justus, E., Matthew, N., & Chukwuemeka, U. (2019). Clinical Profile of Lassa Fever Patients in Abakaliki, South-Eastern Nigeria, January-March 2018. Annals of Medical and Health Sciences Research| Volume, 9(3).
14. [14]14. KARODE, P., BISWAS, M., BHARANI, A., & JAIN, H. (2021). Clinico-bacteriological Profile of Pneumonia, Meningitis and Sepsis in under Five Children from a Tertiary Care Hospital in Central India. Journal of Clinical & Diagnostic Research, 15(9).
15. [15]15. Kerketta, A., & Hiregoudar, M. B. (2018). Clinical profile and outcome of organ dysfunction in sepsis. International Journal of Research in Medical Sciences, 6(6), 1927.
16. [16]16. Kobie, A. G., Okeibunor, J. C., & Gonah, L. (2025). Risk factors and determinants of Lassa fever transmission in Eastern Sierra Leone. Journal of Global Health Economics and Policy, 5.
17. [17]17. Lal, C. V., & Ambalavanan, N. (2015). Biomarkers, early diagnosis, and clinical predictors of BPD. Clinics in perinatology, 42(4), 739.
18. [18]18. Leighl, N. B., Page, R. D., Raymond, V. M., Daniel, D. B., Divers, S. G., Reckamp, K. L., ... & Papadimitrakopoulou, V. A. (2019). Clinical utility of comprehensive cell-free DNA analysis to identify genomic biomarkers in patients with newly diagnosed metastatic non–small cell lung cancer. Clinical Cancer Research, 25(15), 4691-4700.
19. [19]19. Liang, L., Kotadia, N., English, L., Kissoon, N., Ansermino, J. M., Kabakyenga, J., ... & Wiens, M. O. (2018). Predictors of mortality in neonates and infants hospitalized with sepsis or serious infections in developing countries: a systematic review. Frontiers in pediatrics, 6, 277.
20. [20]20. Linné, E., Elfström, A., Åkesson, A., Fisher, J., Grubb, A., Pettilä, V., ... & Bentzer, P. (2022). Cystatin C and derived measures of renal function as risk factors for mortality and acute kidney injury in sepsis–a post-hoc analysis of the FINNAKI cohort. Journal of Critical Care, 72, 154148.
21. [21]21. Liu, J., Xie, H., Ye, Z., Li, F., & Wang, L. (2020). Rates, predictors, and mortality of sepsis-associated acute kidney injury: a systematic review and meta-analysis. BMC nephrology, 21(1), 318.
22. [22]22. Liu, Y., Pears, N., Rosin, P. L., & Huber, P. (Eds.). (2020). 3D imaging, analysis and applications. Cham, Switzerland: Springer International Publishing.
23. [23]23. Méndez Hernández, R., & Ramasco Rueda, F. (2023). Biomarkers as prognostic predictors and therapeutic guide in critically ill patients: clinical evidence. Journal of Personalized Medicine, 13(2), 333.
24. [24]24. Merson, L., Bourner, J., Jalloh, S., Erber, A., Salam, A. P., Flahault, A., & Olliaro, P. L. (2021). Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design. PLOS Neglected Tropical Diseases, 15(9), e0009788.
25. [25]25. Ogundele, G. O., Jolayemi, K. O., & Bello, S. (2025). Lassa fever in West Africa: a systematic review and meta-analysis of attack rates, case fatality rates and risk factors. BMC Public Health, 25(1), 2948.
26. [26]26. Okokhere, P., Colubri, A., Azubike, C., Iruolagbe, C., Osazuwa, O., Tabrizi, S., ... & Sabeti, P. C. (2018). Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study. The Lancet Infectious Diseases, 18(6), 684-695.
27. [27]27. Olayinka, A. T., Elimian, K., Ipadeola, O., Dan-Nwafor, C., Gibson, J., Ochu, C., ... & Ihekweazu, C. (2022). Analysis of sociodemographic and clinical factors associated with Lassa fever disease and mortality in Nigeria. PLOS Global Public Health, 2(8), e0000191.
28. [28]28. Passaro, A., Al Bakir, M., Hamilton, E. G., Diehn, M., André, F., Roy-Chowdhuri, S., ... & Peters, S. (2024). Cancer biomarkers: Emerging trends and clinical implications for personalized treatment. Cell, 187(7), 1617-1635.
29. [29]29. Ponti, G., Maccaferri, M., Ruini, C., Tomasi, A., & Ozben, T. (2020). Biomarkers associated with COVID-19 disease progression. Critical reviews in clinical laboratory sciences, 57(6), 389-399.
30. [30]30. Pregernig, A., Müller, M., Held, U., & Beck-Schimmer, B. (2019). Prediction of mortality in adult patients with sepsis using six biomarkers: a systematic review and meta-analysis. Annals of intensive care, 9(1), 125.
31. [31]31. Rabello Filho, R., Rocha, L. L., Corrêa, T. D., Pessoa, C. M. S., Colombo, G., & Assuncao, M. S. C. (2016). Blood lactate levels cutoff and mortality prediction in sepsis—time for a reappraisal? A retrospective cohort study. Shock, 46(5), 480-485.
32. [32]32. Saka, M. J., Gubio, A. B., Yennan, S. K., Saka, A. O., & Oyemakinde, A. (2017). Lassa fever epidemic in Nigeria-outbreak investigation, risk factors and empirical analysis from 2012 to 2016.
33. [33]33. Sarhadi, V. K., & Armengol, G. (2022). Molecular biomarkers in cancer. Biomolecules, 12(8), 1021.
34. [34]34. Shen, J., Zhang, C. J., Jiang, B., Chen, J., Song, J., Liu, Z., ... & Ming, W. K. (2019). Artificial intelligence versus clinicians in disease diagnosis: systematic review. JMIR medical informatics, 7(3), e10010.
35. [35]35. Steyerberg, E. W. (2019). Clinical prediction models (Vol. 201, No. 9). Cham: Springer International Publishing.
36. [36]36. Sweeney, T. E., Perumal, T. M., Henao, R., Nichols, M., Howrylak, J. A., Choi, A. M., ... & Langley, R. J. (2018). A community approach to mortality prediction in sepsis via gene expression analysis. Nature communications, 9(1), 694.
37. [37]37. Tiamiyu, A. B., Adegbite, O. A., Freides, O., Frndak, S., Mohammed, S. S., Broach, E., ... & Hakre, S. (2024). Seroprevalence and risk factors for Lassa virus infection in South-West and North-Central Nigeria: a community-based cross-sectional study. BMC Infectious Diseases, 24(1), 1118.
38. [38]38. Verykokou, S., & Ioannidis, C. (2023). An overview on image-based and scanner-based 3D modeling technologies. Sensors, 23(2), 596.
39. [39]39. Wang, J., Sun, Y., Teng, S., & Li, K. (2020). Prediction of sepsis mortality using metabolite biomarkers in the blood: a meta-analysis of death-related pathways and prospective validation. BMC medicine, 18(1), 83.
40. [40]40. Zhang, Y., Weng, Y., & Lund, J. (2022). Applications of explainable artificial intelligence in diagnosis and surgery. Diagnostics, 12(2), 237.

Authors (7)